{
    "clinical_study": {
        "@rank": "137688", 
        "arm_group": {
            "arm_group_label": "One patient group", 
            "description": "Patients suffering from irritable bowel syndrome"
        }, 
        "brief_summary": {
            "textblock": "A study to evaluate, by country and overall, the changes from baseline of the irritable\n      bowel syndrome quality of life (IBS QoL) total score after 4 and 8 weeks of treatment with\n      Duspatalin\u00ae or Dicetel\u00ae in IBS patients."
        }, 
        "brief_title": "Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": "Irritable Bowel Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Irritable bowel syndrome patients diagnosed by Rome III criteria (18 years or older)\n\n        Exclusion Criteria:\n\n          -  Pregnancy and lactation\n\n          -  Specific contraindications to mebeverine hydrochloride or pinaverium bromide"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary care clinic, community sample"
            }
        }, 
        "enrollment": {
            "#text": "607", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01678781", 
            "org_study_id": "P13-678"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Mebeverine", 
                "Bromides", 
                "Alverine", 
                "Pinaverium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Abdominal pain", 
            "Diarrhea", 
            "Mebeverine hydrochloride", 
            "Constipation", 
            "Pinaverium bromide", 
            "Irritable bowel syndrome", 
            "Bloating", 
            "Quality of life"
        ], 
        "lastchanged_date": "September 6, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100034"
                    }, 
                    "name": "Site reference ID/Investigator# 94519"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "zip": "510080"
                    }, 
                    "name": "Site reference ID/Investigator# 94521"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou City", 
                        "country": "China", 
                        "zip": "510515"
                    }, 
                    "name": "Site reference ID/Investigator# 95475"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "zip": "200127"
                    }, 
                    "name": "Site reference ID/Investigator # 94518"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "zip": "200433"
                    }, 
                    "name": "Site reference ID/Investigator # 94517"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Site reference ID/Investigator # 94516"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "zip": "430022"
                    }, 
                    "name": "Site reference ID/Investigator # 94515"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alexandria", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 95908"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cairo", 
                        "country": "Egypt"
                    }, 
                    "name": "Site reference ID/Investigator# 95900"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "El Sharkya", 
                        "country": "Egypt"
                    }, 
                    "name": "Site reference ID/Investigator# 95901"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Giza", 
                        "country": "Egypt"
                    }, 
                    "name": "Site reference ID/Investigator# 95902"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Giza", 
                        "country": "Egypt"
                    }, 
                    "name": "Site reference ID/Investigator# 95903"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Said", 
                        "country": "Egypt"
                    }, 
                    "name": "Site Reference ID/Investigator# 95906"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guadalajara", 
                        "country": "Mexico", 
                        "zip": "49000"
                    }, 
                    "name": "Site reference ID/Investigaot# 94525"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico", 
                        "zip": "54055"
                    }, 
                    "name": "Site refernce ID/Investigator# 94527"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampico", 
                        "country": "Mexico", 
                        "zip": "89190"
                    }, 
                    "name": "Site reference ID/Investigator# 94523"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bialystok", 
                        "country": "Poland", 
                        "zip": "15-270"
                    }, 
                    "name": "Site reference ID/Investigator# 85314"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bialystok", 
                        "country": "Poland", 
                        "zip": "15-351"
                    }, 
                    "name": "Site Reference ID/Investigator# 85297"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bydgoszcz", 
                        "country": "Poland", 
                        "zip": "85-079"
                    }, 
                    "name": "Site Reference ID/Investigator# 85298"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Katowice", 
                        "country": "Poland", 
                        "zip": "40-031"
                    }, 
                    "name": "Site Reference ID/Investigator# 85293"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "91-473"
                    }, 
                    "name": "Site Reference ID/Investigator# 85296"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olsztyn", 
                        "country": "Poland", 
                        "zip": "10-501"
                    }, 
                    "name": "Site reference ID/Investigator# 85313"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poznan", 
                        "country": "Poland", 
                        "zip": "60-193"
                    }, 
                    "name": "Site Reference ID/Investigator# 85295"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poznan", 
                        "country": "Poland", 
                        "zip": "60-539"
                    }, 
                    "name": "Site Reference ID/Investigator# 85294"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "China", 
                "Egypt", 
                "Mexico", 
                "Poland"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Open International Study on Quality of Life in IBS Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide", 
        "overall_official": {
            "affiliation": "Abbott", 
            "last_name": "Guenter  Krause", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "China: Ethics Committee", 
                "Egypt: Ministry of Health and Population", 
                "Mexico: Federal Commission for Sanitary Risks Protection"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in Irritable Bowel syndrome (IBS) quality of life (QoL) measure (IBS-QoL) to assess the impairment of QoL in IBS patients", 
            "safety_issue": "No", 
            "time_frame": "From baseline up to the week 8 visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01678781"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in bloating", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in feeling of abdominal distension", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in stool frequency", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in stool form", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in straining of evacuation", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in urgency of evacuation", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }, 
            {
                "measure": "Change in feeling of incomplete evacuation", 
                "safety_issue": "No", 
                "time_frame": "From baseline up to the week 8 visit"
            }
        ], 
        "source": "Abbott", 
        "sponsors": {
            "collaborator": {
                "agency": "CHILTERN International GmbH", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Abbott", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}